Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts

被引：0
|
作者：
Mustafa T. Ardah
Simona S. Ghanem
Sara A. Abdulla
Guohua Lv
Mohamed M. Emara
Katerina E. Paleologou
Nishant N. Vaikath
Jia-Hong Lu
Min Li
Konstantinos Vekrellis
David Eliezer
Omar M. A. El-Agnaf
机构：
[1] United Arab Emirates University,Department of Biochemistry, College of Medicine and Health Science
[2] Hamad Bin Khalifa University (HBKU),Neurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI)
[3] Education City,Department of Biochemistry
[4] Qatar Foundation,Basic Medical Sciences Department, College of Medicine, QU Health
[5] Weill Cornell Medical College,Department of Molecular Biology and Genetics
[6] Qatar University,State Key Lab of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences
[7] Democritus University of Thrace,School of Chinese Medicine
[8] University of Macau,Center of Basic Research
[9] Hong Kong Baptist University,undefined
[10] Biomedical Research Foundation of the Academy of Athens,undefined
来源：
BMC Complementary Medicine and Therapies | / 20卷
关键词：
α-Synuclein; Parkinson’s disease; Seeded fibril formation; Amyloid fibrils; Salvianolic acid B; Dihydromyricetin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
    Rachel Underwood
    Mary Gannon
    Aneesh Pathak
    Navya Kapa
    Sidhanth Chandra
    Alyssa Klop
    Talene A. Yacoubian
    Acta Neuropathologica Communications, 9
  • [22] Unbiased Screens for Modifiers of Alpha-Synuclein Toxicity
    Hoellerhage, Matthias
    Bickle, Marc
    Hoeglinger, Guenter U.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2019, 19 (02)
  • [23] Unbiased Screens for Modifiers of Alpha-Synuclein Toxicity
    Matthias Höllerhage
    Marc Bickle
    Günter U. Höglinger
    Current Neurology and Neuroscience Reports, 2019, 19
  • [24] Mechanisms of alpha-synuclein toxicity: An update and outlook
    Bras, Ines Caldeira
    Xylaki, Mary
    Outeiro, Tiago Fleming
    RECENT ADVANCES IN PARKINSON'S DISEASE, 2020, 252 : 91 - 129
  • [25] Insights Into Peptide Inhibition of Alpha-Synuclein Aggregation
    Torpey, James H.
    Meade, Richard M.
    Mistry, Ravina
    Mason, Jody M.
    Madine, Jillian
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [26] Inhibition of fibril formation and toxicity of a fragment of α-synuclein by an N-methylated peptide analogue
    Bodles, AM
    El-Agnaf, OMA
    Greer, B
    Guthrie, DJS
    Irvine, GB
    NEUROSCIENCE LETTERS, 2004, 359 (1-2) : 89 - 93
  • [27] Detection of Alpha-Synuclein Using Fibril Conformation-Selective Antibodies
    Akhtar, Rizwan S.
    Licata, Joseph P.
    Covell, Dustin J.
    Luk, Kelvin C.
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    ANNALS OF NEUROLOGY, 2017, 82 : S116 - S116
  • [28] Phagocytosis Assay for alpha-Synuclein Fibril Uptake by Mouse Primary Microglia
    Du, Cuilian
    Zhang, Feifan
    Zhang, Claire Xi
    BIO-PROTOCOL, 2018, 8 (17):
  • [29] Threonine Cavities Are Targetable Motifs That Control Alpha-Synuclein Fibril Growth
    Kochen, Noah Nathan
    Vasandani, Vivek
    Seaney, Darren
    Pandey, Anil K.
    Walters, Michael A.
    Braun, Anthony R.
    Sachs, Jonathan N.
    ACS CHEMICAL NEUROSCIENCE, 2022, 13 (17): : 2646 - 2657
  • [30] Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity
    Luk, Kelvin C.
    Covell, Dustin J.
    Kehm, Victoria M.
    Zhang, Bin
    Song, Insung Y.
    Byrne, Matthew D.
    Pitkin, Rose M.
    Decker, Samantha C.
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    CELL REPORTS, 2016, 16 (12): : 3373 - 3387
12345